SCHEMBL7252575

SCHEMBL7252575

COc1cccc(N2CCNCC2)c1.Cn1c(CCc2ccc(C(N)=NO)cc2)nc2cc(C(=O)O)ccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 1/20 0.44
▸ F2 P00734 1/20 0.42
▸ ADRB1 P08588 1/20 0.42
▸ NTRK1 P04629 3/20 0.40
▸ NTRK2 Q16620 3/20 0.40
▸ PPARG P37231 2/20 0.39
▸ HCAR3 P49019 1/20 0.39
▸ HTR2C P28335 1/20 0.39
▸ HDAC1 Q13547 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ TP53 P04637 2/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ CYP2D6 P10635 2/20 0.37
▸ HDAC6 Q9UBN7 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ USP2 O75604 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7249812 0.93 PPARG (0.42) THRBF2NTRK1NTRK2PPARG
SCHEMBL7249727 0.93 F2 (0.41) THRBF2NTRK1NTRK2HTR2C
SCHEMBL7249842 0.91 F2 (0.43) F2ADRB1NTRK1NTRK2HTR2C
SCHEMBL7250212 0.84 F2 (0.45) THRBF2ADRB1NTRK1NTRK2
SCHEMBL7250244 0.83 HTR2C (0.45) F2HTR2CHDAC1HDAC8HDAC6
SCHEMBL7253523 0.83 F2 (0.47) F2NTRK1NTRK2HTR2CHDAC1
SCHEMBL7248203 0.82 F2 (0.42) F2NTRK1NTRK2HTR2CHDAC1
SCHEMBL7243857 0.82 F2 (0.54) THRBF2NTRK1NTRK2HDAC1
SCHEMBL7256417 0.81 F2 (0.43) F2HCAR3HTR2CHDAC1HDAC8
Phenylpiperazine SCHEMBL7248311 0.80 HTR2C (0.46) F2NTRK1NTRK2HTR2CHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6512000-B1 Aminocarbonyl- substituted benzimidazole derivatives for the treatment of diseases in which inhibition of tryptase is of therapeutic such as for treating an inflammatory or allergic disease BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-01-28 — — US disclosed
Send feedback